Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00626158 | Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers | completed | Phase 1 | 45 | University of California, San FranciscoOTHER | 1 | Apr 4, 2012 | clinicaltrials |
| NCT01570452 | Matrilysin Expression in Different Stages of Colorectal Tumors(MMP7) | completed | — | 38 | University of Roma La SapienzaOTHER | 1 | Apr 4, 2012 |
| clinicaltrials |
| NCT00499395 | Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer | completed | N/A | 4 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00662246 | Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular Carcinoma | completed | Phase 1 | 24 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00473980 | Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients | completed | Phase 4 | 28 | Göteborg UniversityOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT01320241 | Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture | completed | Phase 2 | 24 | Southeast University, ChinaOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT00499265 | Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 95 | Heidelberg Pharma AGINDUSTRY | 6 | Mar 29, 2012 | clinicaltrials |
| NCT01025960 | A Comparison of Methods to Detect Polyps During Colonoscopy | completed | N/A | 768 | The Cleveland ClinicOTHER | 1 | Mar 27, 2012 | clinicaltrials |
| NCT00660205 | Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer(GIVTE) | completed | — | 285 | University of AarhusOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00784290 | Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 35 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00019786 | Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases | completed | Phase 2 | 67 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT01387880 | Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer(ICE) | completed | Phase 2 | 100 | Herlev HospitalOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00547612 | Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer | completed | Phase 1 | 33 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00734890 | Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 18 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00030108 | Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00031941 | CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00036959 | ABT-751 in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 90 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00088868 | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma | completed | Phase 1 | 40 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00093444 | Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 2 | Mar 15, 2012 | clinicaltrials |
| NCT00303940 | Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors | completed | Phase 1 | 26 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00988195 | Study of Pegylated Human Recombinant Arginase for Liver Cancer | completed | Phase 1 | 15 | Bio-Cancer Treatment International LimitedINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01092091 | Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)(BCT-100-002) | completed | Phase 1 / Phase 2 | 20 | Bio-Cancer Treatment International LimitedINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01238666 | Evaluation of a Minimally Invasive Image-Guided Surgery System for Hepatic Ablation Procedures | completed | — | 27 | Pathfinder TherapeuticsINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01286428 | Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures | completed | — | 30 | Pathfinder TherapeuticsINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT00054977 | Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors | completed | Phase 1 | 40 | Galectin Therapeutics Inc.INDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00003254 | SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil | completed | Phase 2 | 75 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00020501 | Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | completed | Phase 3 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00559598 | Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer | completed | — | 502 | National Institutes of Health Clinical Center (CC)NIH | 0 | Mar 8, 2012 | clinicaltrials |
| NCT01373021 | The Effect of Dexmedetomidine on Postoperative Analgesia | completed | Phase 4 | 95 | Seoul National University HospitalOTHER | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00266097 | Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | completed | Phase 1 | 23 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 7, 2012 | clinicaltrials |
| NCT01175447 | S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer | completed | Phase 1 | 12 | Zhejiang Cancer HospitalOTHER | 1 | Mar 6, 2012 | clinicaltrials |
| NCT01175460 | S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer | completed | Phase 1 | 15 | Zhejiang Cancer HospitalOTHER | 1 | Mar 6, 2012 | clinicaltrials |
| NCT00002722 | High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | completed | Phase 2 | 135 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Mar 5, 2012 | clinicaltrials |
| NCT01543412 | Second Line Chemotherapy for Advanced Pancreatic Cancer(SLAP) | completed | Phase 2 | 50 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Mar 5, 2012 | clinicaltrials |
| NCT00786643 | Study of Gamma Interfereon in Metastatic Colorectal Carcinoma(GFL) | completed | Phase 2 | 48 | Accelerated Community Oncology Research NetworkOTHER | 1 | Mar 1, 2012 | clinicaltrials |
| NCT01147991 | Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer | completed | Phase 1 | 16 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00051467 | A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer | completed | Phase 3 | — | GenVecINDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00137878 | TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer | completed | Phase 2 | — | GenVecINDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00932308 | Colorectal Inflammatory Response to a Western-Style Diet | completed | N/A | 5 | Rockefeller UniversityOTHER | 1 | Feb 17, 2012 | clinicaltrials |
| NCT00068575 | Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | completed | Phase 2 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00912327 | Efficacy and Safety Study of Imprime PGG With Cetuximab in Subjects With Stage IV KRAS-Mutated Colorectal Cancer | completed | — | 18 | HiberCell, Inc.INDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00074009 | Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00257426 | Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer | completed | Phase 2 | 31 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00280176 | Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | completed | Phase 1 | 11 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00913198 | A Study of CP-4126 in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 21 | Clavis PharmaINDUSTRY | 2 | Feb 10, 2012 | clinicaltrials |
| NCT00952497 | A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer | completed | Phase 2 | 48 | ACT Biotech, IncINDUSTRY | 2 | Feb 8, 2012 | clinicaltrials |
| NCT00176774 | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma | completed | Phase 2 | 24 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
Data updated 24 days agoSource updated Apr 4, 2012source: clinicaltrials